Dachaigh › Lymphoma › Pennsylvania › Philadelphia
Sgrùdaidhean clionaigeach Lymphoma ann an Philadelphia, PA
Tha 15 sgrùdaidhean airson Lymphoma a’ lorg phàirtichean aig làraichean ann agus timcheall air Philadelphia (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A’ fastadhSgrùdadh amharc
- Children's Hospital of Philadelphia, Philadelphia
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
A’ fastadhÌre 1
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
A’ fastadhÌre 2
- University of Pennsylvania, Philadelphia
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
A’ fastadhÌre 1/2
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
A’ fastadhÌre 1
- The Children's Hospital of Philadelphia (CHOP), Philadelphia
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
A’ fastadhÌre 1/2
- Research Site, Philadelphia
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
A’ fastadhÌre 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
A’ fastadhÌre 1
- Thomas Jefferson University, Philadelphia
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
A’ fastadhÌre 1
- Hospital of the University of Pennsylvania, Philadelphia
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A’ fastadhÌre 1/2
- Thomas Jefferson University, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
A’ fastadhÌre 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
A’ fastadhÌre 1
- Children's Hospital of Philadelphia, Philadelphia
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
A’ fastadhSgrùdadh amharc
- Saint Christopher's Hospital for Children, Philadelphia
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
A’ fastadhÌre 1
- University of Pennsylvania - Abramson Caner Center, Philadelphia
Sgrùdaidhean Lymphoma ann am bailtean eile
- Houston, TX34 sgrùdaidhean
- Boston, MA33 sgrùdaidhean
- New York City, NY33 sgrùdaidhean
- Washington, DC23 sgrùdaidhean
- Baldwin Park, CA21 sgrùdaidhean
- Chicago, IL20 sgrùdaidhean
- Durham, NC17 sgrùdaidhean
- St. Louis, MO15 sgrùdaidhean
- Cleveland, OH14 sgrùdaidhean
- Edison, NJ12 sgrùdaidhean
- Atlanta, GA12 sgrùdaidhean
- Seattle, WA12 sgrùdaidhean
Sgrùdaidhean eile ann an Philadelphia
- Aillse (gach seòrsa)59 sgrùdaidhean
- Aillse a' bhroilleach56 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag51 sgrùdaidhean
- Ailse metastatach46 sgrùdaidhean
- Aillse colorectal44 sgrùdaidhean
- Cancer Ovarian44 sgrùdaidhean
- Aillse Prostata44 sgrùdaidhean
- Ailseachadh nan Sgamhan36 sgrùdaidhean
- Leukemia myeloid geur34 sgrùdaidhean
- Fàilligeadh a' Chridhe31 sgrùdaidhean
- Ailse Endometrial28 sgrùdaidhean
- Depression26 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.